Epic Sciences

This person does not yet have a bio.

Content by Epic Sciences

| 6 min read

Guest Commentary: Back to cancer’s drawing board

Decades after the precision medicine revolution began, it is worth assessing whether the evidence still supports genomics as the primary pillar upon which to understand cancer and make treatment decisions

Articles

Page 1 of 1 - 1 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Abstract rainbow-colored beams of light spreading across a dark background.

How to choose the right fluorochromes for complex flow cytometry panels

Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.

Whitepaper

Illustration of multiple glowing blue and purple spherical cells against a dark blue background.

Technology Guide: High-content analysis in modern drug discovery

As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.

Technology Guides

3D illustration of protein receptors embedded in a cell membrane interacting with small molecules.

Mapping degrader activity and selectivity in intact cells

Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.

Webinars

Epic Sciences

Guest Commentary: Back to cancer’s drawing board

Subscribe to our eNewsletters

Sponsored